Head-to-Head Comparison of (68)Ga-PSMA-11 and (131)I in the Follow-Up of Well-Differentiated Metastatic Thyroid Cancer: A New Potential Theragnostic Agent

INTRODUCTION: Thyroid cancer is the main endocrine neoplasia worldwide, for which (131)I therapy is the cornerstone treatment. One of the main problems of follow up in patients with this type of cancer, is the need for thyroglobulin stimulation, not to mention the poor availability of (123)I or (124...

Descripción completa

Detalles Bibliográficos
Autores principales: Pitalua-Cortes, Quetzali, García-Perez, Francisco Osvaldo, Vargas-Ahumada, Joel, Gonzalez-Rueda, Sofia, Gomez-Argumosa, Edgar, Ignacio-Alvarez, Eleazar, Soldevilla-Gallardo, Irma, Torres-Agredo, Liliana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727771/
https://www.ncbi.nlm.nih.gov/pubmed/35002972
http://dx.doi.org/10.3389/fendo.2021.794759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727771/
https://www.ncbi.nlm.nih.gov/pubmed/35002972
http://dx.doi.org/10.3389/fendo.2021.794759

Ejemplares similares